Stroke

Latest News

Frequency of Acute Ischemic Stroke Decreased in COVID-19 Patients

Acute ischemic stroke is infrequent in patients with COVID-19 and usually occurs in the presence of other cardiovascular risk factors.

Mesenchymal Stem Cell Therapy Has Modest Benefits for Chronic Major Stroke

The primary goal of this study was to assess whether autologous modified mesenchymal stem cells improve recovery in patients with chronic major stroke.

Stroke and Systemic Embolism Risk Is Highest with HFpEF Among Heart Failure Types

Study authors assessed the risk of stroke and systemic embolism in patients with atrial fibrillation and heart failure according to HF types.

Greater Frequency of Stroke in Men With COVID-19 and High Comorbidity Burden

At the 2021 International Stroke Conference, researchers presented their findings on stroke among men with COVID-19 and high comorbidity burden.

Antihypertensive Medication Recalled Due to Label Mix-Up

Telmisartan, an angiotensin II receptor blocker, is indicated for the treatment of hypertension.

Black Americans Underrepresented in Cardiovascular Drug Trials

Black residents are underrepresented as participants in clinical trials to support the approval of cardiovascular drugs in the United States.

Increased Risk for PSD in Elderly Women Following Ischemic Stroke

At the 2021 International Stroke Conference, researchers presented their findings on the differences in poststroke depression between elderly men and women.

Mechanical Thrombectomy: A Viable Option for Managing Posterior Circulation DMVOs

Researchers investigated the clinical and safety outcomes of mechanical thrombectomy for isolated posterior circulation DMVO stroke and compared them with standard medical treatment.

Black Patients May Have Higher Mortality Risk After Ischemic Stroke

Study researchers presented their findings regarding race differences in 10-year mortality following ischemic stroke during the 2021 International Stroke Conference.

Effectiveness of Anticoagulants Compared for Valvular A-Fib

For patients who are new to therapy for valvular atrial fibrillation (AF), direct oral anticoagulants (DOACs) as a class are effective and safe compared with warfarin, with some variability among individual DOACs